Retatrutide pens versus research vials in the UAE

VaultLabs catalogs retatrutide-class research material as GLP-3 RT in nominal 5, 10, 15, 20, and 30 mg lyophilized formats. Both are sealed glass vials of dry powder. There is no pen, cartridge, or prefilled presentation anywhere in the VaultLabs catalog, and there is no plan to add one.

This is a scope boundary rather than a stock issue. A prefilled pen is a finished-format delivery device designed around human pharmaceutical presentation. Research-use-only supply covers reference material for in vitro laboratory work, so a pen format would contradict the terms every VaultLabs lot is supplied under.

If you searched for a retatrutide pen and landed here, the honest answer is that a research supplier is not the right source for that format. What we can supply is documented, lot-traceable reference material on the GLP-3 RT product page.

Lyophilized (freeze-dried) powder is the stable form for a peptide in transit and storage. Removing water slows the degradation pathways that shorten the usable life of a peptide in solution, which is why reference material intended to sit in a laboratory freezer arrives dry rather than pre-mixed.

A sealed dry vial also lets the laboratory control the diluent, the concentration, and the record of both — decisions that belong to the receiving laboratory's own SOP, not to the supplier. VaultLabs lists bacteriostatic water separately for exactly that reason.

Sealed GLP-3 RT records specify 2–8 °C storage with protection from light and moisture. The research peptide storage guide covers handling on receipt; the laboratory's validated procedure remains controlling once a vial is opened.

Searches like "retatrutide 10mg pen" and "retatrutide 20mg pen" use the same milligram vocabulary as our vial strengths, which is why the two get confused. The number refers to the mass of peptide in the unit, so a 10 mg figure describes the same quantity of material in either format.

What differs is everything around that number. A vial states a nominal dry mass that the receiving laboratory prepares according to its own procedure. A pen implies a fixed, pre-prepared concentration and a metering mechanism — parameters set by whoever assembled it, which a research buyer cannot independently confirm.

VaultLabs publishes the nominal mass, the lot number, and the analytical record for each strength. Match the product, strength, and lot on the physical label against the published record rather than assuming a figure quoted in a listing describes the same thing.

Every GLP-3 RT unit is inventory-tracked against a lot number printed on the vial label. Enter that number into batch verification to pull the published record for the specific lot in your hand, rather than a generic catalog description. The current 10 mg shipping lot and the laboratory named on that certificate are on the Retatrutide UAE overview and the published GLP-3 RT 10mg certificate.

Published records label their document type — independent analytical laboratory versus supplier-generated. A PDF alone does not establish independent testing, and the COA interpretation guide walks through the identity, purity, and lot fields worth checking before material enters a qualification workflow.

Informal pen listings typically arrive with no lot number, no published certificate, and no route back to an analytical record. That absence is the practical difference between documented research supply and an unverifiable purchase — the supplier evaluation guide covers how to assess this.

GLP-3 RT and every other VaultLabs material is supplied strictly for in vitro laboratory research. It is not for human consumption, medical use, personal use, veterinary use, or diagnostic use.

VaultLabs does not provide dosing figures, administration guidance, preparation protocols for personal application, or weight-management information of any kind, in any format. Questions of that nature fall outside what a research supplier can answer.

Buyers are responsible for confirming that their intended use complies with UAE regulations and their institution's review requirements.